Ph.D. Roger Y. TSIEN

Nobel Laureate in Chemistry; Professor of Pharmacology, Chemistry and Biochemistry, University of California; Investigator, Howard Hughes Medical Institute, San Diego

1972	Received his A.B. in Chemistry and Physics, Harvard College
	until 1981 Research Fellow, University of Cambridge
1977	Ph.D. in Physiology, University of Cambridge
1981	First Assistant, Associate, then full Professor, University of California, Berkeley
1989	Investigator, Howard Hughes Medical Institute and Professor, Departments of Pharmacology and of Chemistry & Biochemistry, University of California, San Diego
1996	Scientific Co-founder, Aurora Biosciences Corporation, which went public in 1997
	Dr. Tsien is best known for designing and building molecules that either report or perturb signal transduction inside living cells. These molecules, created by organic synthesis or by engineering naturally fluorescent proteins, have enabled many new insights into signaling via calcium, sodium, pH, cyclic nucleotides, nitric oxide, inositol polyphosphates, membrane and redox potential changes, protein phosphorylation, active export of proteins from the nucleus, and gene transcription. He is now developing new ways to target contrast agents and therapeutic agents to tumor cells and atherosclerotic plaques based on their expression of extracellular proteases.
1998	Scientific Co-founder, Senomyx Inc., which went public in 2004

Dr. Michael PRÜLLER

Stellvertretender Chefredakteur, Die Presse, Wien

1986	Dr. juris, Paris-Lodron-Universität Salzburg
1987	Diplomstudium, Institut Européen des Hautes Etudes Internationales, Nizza
1996-1999	Senior Consultant, PR- und Werbeagentur Ogilvy & Mather, Wien
2000-2004	Ressortleiter, Wirtschaftsressort ("Economist"), Tageszeitung "Die Presse"
seit 2004	Stellvertretender Chefredakteur, Tageszeitung "Die Presse"